隆盛科技(300680.SZ):子公司微研精密再獲驅動電機鐵芯產品供應商定點並簽署採購協議
格隆匯 12 月 11日丨隆盛科技(300680.SZ)公佈,公司全資子公司無錫微研精密衝壓件有限公司(“微研精密”)於近日與一家在中國的外資電動汽車及能源公司簽訂了驅動電機鐵芯產品的生產定價採購協議。
公司目前正在積極推進為該客户配套驅動電機鐵芯產品的量產準備工作,2021年起,微研精密將依據雙方簽訂的採購協議開始為該客户提供驅動電機鐵芯產品。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.